EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Endovascular treatment of TransAtlantic Inter-Society Consensus D aortoiliac occlusive disease using unibody bifurcated endografts



Endovascular treatment of TransAtlantic Inter-Society Consensus D aortoiliac occlusive disease using unibody bifurcated endografts



Journal of Vascular Surgery 65(2): 398-405



Label="OBJECTIVE">Aortobifemoral bypass has been the gold standard treatment for extensive aortoiliac occlusive disease. Endovascular therapy and stenting of aortic and iliac occlusive lesions has proven to be efficacious, especially when dealing with short segment lesions. Endovascular treatment of TransAtlantic Inter-Society Consensus II (TASC) D aortoiliac occlusive lesions remains a challenge, but a valuable treatment option in poor surgical candidates. We present our operative technique and midterm results in treating TASC D aortoiliac occlusive disease using unibody bifurcated endografts.Label="METHODS">We performed a retrospective review of patients with TASC D aortoiliac occlusive disease who underwent transfemoral endovascular revascularization with the Endologix Powerlink unibody bifurcated endograft (Endologix, Irvine, Calif). Demographic data, operative details, and outcomes were collected. Paired t-tests were performed to compare preoperative and postoperative ankle brachial indexes.Label="RESULTS">Between March 2009 and July 2011, 10 high-risk patients (8 male and 2 female) for a traditional aortobifemoral bypass were treated using this endovascular technique. The mean age was 59 ± 6 years (range, 50-69 years). All patients presented with rest pain, and four with tissue loss. Technical success was 100%, with two patients requiring brachial access and eight patients requiring additional stent placement. Postoperatively, all patients reported clinical improvement with resolution of ischemic symptoms. Mean improvement ankle brachial index was 0.50 ± 0.08 (P = .028) and 0.50 ± 0.01 (P = .034) in the left and right legs, respectively. Mean follow-up time was 40 ± 24 months (range, 4-81 months). The primary and secondary patency rates were 80% and 100%, respectively. Complications requiring early reintervention occurred in two patients and included one expanding hematoma from the percutaneous access site and one acute iliac artery thrombosis. Additionally, one patient underwent repeat angioplasty/stenting for threatened endograft limbs at 4 months. One patient expired during follow-up from an unrelated cardiac cause 19 weeks postoperatively.Label="CONCLUSIONS">This series demonstrates that endovascular repair using a unibody bifurcated endograft for TASC D aortoiliac occlusive disease is feasible, effective, and has excellent midterm patency. It should be considered an effective treatment option when the disease process involves the aorta, in particular if the patient is surgically unfit for a traditional aortobifemoral bypass. The unibody configuration preserves the anatomic aortic bifurcation, which is particularly important in patients with peripheral occlusive disease who are deemed to undergo subsequent endovascular interventions.

(PDF emailed within 0-6 h: $19.90)

Accession: 057767305

Download citation: RISBibTeXText

PMID: 27765483

DOI: 10.1016/j.jvs.2016.08.084



Related references

Results of endovascular therapy and aortobifemoral grafting for Transatlantic Inter-Society type C and D aortoiliac occlusive disease. Surgery 144(4): 583-9; Discussion 589-90, 2008

IP035. Results of AFX Unibody Stent Graft Implantation in Patients Presenting TransAtlantic Inter-Society Consensus Aortoiliac D Lesions and Coexistent Abdominal Aortic Aneurysms. Journal of Vascular Surgery 65(6): 65s-66s, 2017

Hybrid revascularization combining iliofemoral endarterectomy and iliac stent grafting for TransAtlantic Inter-Society Consensus C and D aortoiliac occlusive disease. Annals of Vascular Surgery: -, 2018

Endovascular intervention in aortoiliac disease is associated with sustained long-term benefit independent of the lesion complexity based upon Transatlantic Inter-Society Consensus (TASC) classification. Cardiovascular Revascularization Medicine 10(3): 199-0, 2009

Open and Endovascular Treatment of Trans-Atlantic Inter-Society Consensus II D Aortoiliac Occlusive Lesions: What Determines the Rate of Restenosis?. Chinese Medical Journal 128(22): 3035-3042, 2015

Increasing efficacy of endovascular recanalization with covered stent graft for TransAtlantic Inter-Society Consensus II D aortoiliac complex occlusion. Journal of Vascular Surgery 62(5): 1219-1226, 2016

Comparison of results of endovascular stenting and bypass grafting for TransAtlantic Inter-Society (TASC II) type B, C and D iliac occlusive disease. Archives of Medical Science 12(2): 353-359, 2016

Percutaneous transluminal revascularization for iliac occlusive disease: long-term outcomes in TransAtlantic Inter-Society Consensus A and B lesions. Annals of Vascular Surgery 19(3): 352-360, 2005

Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia. Journal of Vascular Surgery 2019, 2019

AS-44: Factors of Success and Patency after Subintimal Angioplasty in Patients with TransAtlantic Inter-Society Consensus C and D Severe Lower Extremity Occlusive Disease. American Journal of Cardiology 105(9-Supp-S): 20-21, 2010

Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. Journal of Vascular Surgery 43(1): 32-39, 2006

Treatment of Aortoiliac Occlusive Disease with the Endologix AFX Unibody Endograft. European Journal of Vascular and Endovascular Surgery 52(1): 64-74, 2016

Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center. Vascular 23(1): 31-40, 2015

Endovascular management of TransAtlantic Inter-Society Consensus D iliac artery occlusion secondary to radiation arteritis. Journal of Vascular Surgery Cases and Innovative Techniques 4(2): 109-111, 2018

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions. Journal of Vascular Surgery 56(6): 1598-1605, 2013